ARMISTICE CAPITAL, LLC - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 87 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2022. The put-call ratio across all filers is 5.07 and the average weighting 0.7%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$20,760,000
-19.1%
400,000
-6.5%
0.32%
-14.3%
Q2 2023$25,662,880
+37.3%
428,000
+13.2%
0.37%
+37.9%
Q1 2023$18,688,320
-2.5%
378,000
+12.5%
0.27%
-19.7%
Q4 2022$19,175,520
+29.3%
336,000
+6.3%
0.34%
+30.4%
Q3 2022$14,833,000
+48.3%
316,000
+17.9%
0.26%
+47.7%
Q2 2022$9,999,000
+85.8%
268,000
+48.9%
0.17%
+67.3%
Q1 2022$5,382,000180,0000.10%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$34,592,30327.53%
RTW INVESTMENTS, LP 6,029,633$361,536,7956.88%
Paradigm Biocapital Advisors LP 1,270,124$76,156,6355.88%
Rock Springs Capital Management LP 3,028,410$181,583,4644.32%
Logos Global Management LP 500,000$29,980,0004.08%
TANG CAPITAL MANAGEMENT LLC 405,600$24,319,7763.58%
GREAT POINT PARTNERS LLC 297,082$17,813,0373.49%
Eschler Asset Management LLP 34,000$2,038,6402.89%
COWEN AND COMPANY, LLC 460,036$27,583,7582.29%
HighVista Strategies LLC 44,094$2,643,8761.21%
View complete list of IMMUNOCORE HLDGS PLC shareholders